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ABSTRACT  
Public health planning continues to be troubled by the uncertainty of the 
extent of hidden drug use. Methods for estimating the prevalence of opiate 
use are discussed. These include multisource enumeration, death multiplier, 
multiple indicator, and capture-recapture methods. The feasibility and data 
requirements for each of these methods is illustrated for the first time in an 
Irish context. Estimates presented are the result of years of intensive 
collaboration between previously unconnected government, health, and legal 
agencies. Finally, the implications of the methods and their results for the 
planning and provision of medical and social policy are highlighted and 
discussed.  
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For conscientious policy makers dealing with drug problems at (he national and local 
levels, prevalence estimation ought to be a fundamental element of sensible decision 
making (1). 
 
INTRODUCTION  
Interest in developing and implementing methods for estimating drug use 
prevalence and related medical, social, and economic problems is expanding on both a 
European and global level. Evidence for this phenomenon can be seen in the recent 
emergence of multidisciplinary international networks of researchers and related 
publications on local, national, and global drug use prevalence and implications (2-6). 
This phenomenon, however, pre-empts the questions of what prevalence is, why this 
predilection with its estimation, and what reliable methods are available and universally 
applicable for its estimation. In this paper the rationale behind prevalence estimation is 
defined and explained and the generally applicable methods for its estimation are 
critically evaluated. These are then illustrated for the first time in an Irish context and 
finally the wider implications of prevalence results for policy planning are discussed.  
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According to Hay (7), the prevalence of a certain social attribute is defined as the 
proportion of people possessing that attribute. This may be expressed as a percentage 
or as a rate. This may be expressed as a certain number per hundred, per thousand, or 
per hundred thousand of the total population. Sometimes the actual number of 
individuals is used instead of the prevalence. Without previous knowledge of the size of 
the total population, use of the actual number possessing the attribute can be 
misleading. A recent study of opiate use in five European cities showed that the number 
of opiate users in Rome in 1996 was similar to the number of opiate users in Dublin in 
the same year. This may lead one to assume that the size of the problem in the two 
cities was of a similar scale. However, on closer examination of the prevalence rates it 
was seen that the prevalence rate in Dublin was approximately twice that of Rome (8). In 
addition, it is important to stress that the concept of prevalence also requires some 
indication of the time period that is being examined. Drug use and means of taking drugs 
can be transient activities and are subject to availability and fashion. In addition, drug 
use should also take into consideration a drug’s action, that is short-term as in cocaine 
and crack or long-term action as with psychedelics such as LSD, where time perspective 
is also badly affected.  
Clearly in an area as highly politicized as drug use, budgetary decisions, elections, 
and political will are of importance. When one estimates prevalence of opiate use it is 
also important to define what is being estimated, why it is being estimated, and when is it 
to be estimated. What is to be counted and what is the case definition? In some studies 
the definition of a case may refer to heroin dependence or heroin addiction. In others the 
case may be an intravenous heroin user or may even be a prescribed methadone user. 
Hartnoll discusses this issue in a multi-centered European context. He states that the 
answer to the question of what is being measured is closely linked to the purpose and 
why a prevalence estimate is sought. If the purpose of an opiate prevalence estimate is 
to assess possible treatment needs, then the definition should relate to potential clients 
or future clients. If it is to assess demand and the extent of the illicit market then all 
opiate users should be included regardless of their likelihood of seeking treatment (9).  
Finally once the rationale for a prevalence study is decided, the case defined, and 
numbers estimated, it is imperative that such studies are not viewed as a final or 
endpoint, but, rather as a first step in a dynamic and progressive process. Further 
information and interdisciplinary collaboration between an academic and politician is 
necessary for the provision of relevant action, policy development, and service planning. 
Unfortunately, it is often the case that policy decision makers in this area are not 
influenced by available research. Likewise, researchers continue to remain in the 
academic realm with little regard to application and the notion of the “Transfer of 
Technology” remains an ideal.  
METHODS FOR ESTIMATING PREVALENCE AND THEIR DATA REQUIREMENTS  
General Population Surveys  
One of the traditional and most familiar methods used to estimate prevalence of 
drug use in a population is a survey based on random sampling of the population 
concerned. This method has been widely used within localities (10) and countries (11). 
When an inter-country comparison is required this method proves costly to administer 
and difficult to ensure comparability of case definition. The exception to this is when a 
specific subgroup of the population is targeted. A recent illustration of the advantages 
and limitations of such a project is the European School Survey Project on Alcohol and 
Other Drugs, a survey of substance abuse among school-aged children (12). A summary 
of results on lifetime prevalence of any illicit drug is provided in Table 1. Despite the 
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relative success of the ESPAD study, there are some types of drug use that often cannot 
be assessed reliably by this method. These would include the rarer or stigmatized 
problematic patterns of drug use such as intravenous drug use or illegal opiate use. As a 
result, alternative methods are needed to complement the information obtained in such 
population surveys.  
Case Finding: Multisource Enumeration  
Another obvious and popular method for estimating opiate use is the multisource 
enumeration or intensive case finding method (13). This method may be of value in 
provincial towns where the numbers of addicts are small. Even within this context the 
method has its drawbacks. In a smaller town one may have the advantage of having 
access to all the different sources of data on opiate cases but to avoid over-counting, it 
is necessary to identify overlaps within and between the data sources. This may lead to 
the disclosure of confidential information on an individual case, in addition, the 
researcher is still presented with the problem of the hidden opiate drug user. It is widely 
accepted that case notifications under-represent the total opioid-using population. When 
the number of hidden users is missed or unknown this can have serious implications for 
the planning and financial provision of the necessary treatment services. For example, 
education and awareness campaigns may be targeted at the gender and age group in 
treatment and may miss the hidden group that may be of a different age or gender or 
even geographical location within a city or region. An example of a multisource 
enumeration study is provided in the Results section.  
 
Table 1. Lifetime Experience of Any Illicit Drug (Percentages Among All Students)  
United Kingdom  42  
United States  41  
Ireland  37  
Czech Republic  23  
Italy  21  
Denmark  18  
Ukraine  14  
Slovenia  13  
Faroe Island  12  
Iceland  10  
Slovak Republic  10  
Poland  9  
Croatia  8  
Estonia  8  
Portugal  8  
Cyprus  6  
Norway  6  
Sweden  6  
Finland  5  
Hungary  5  
Istanbul  5  
Lithuania  3  
Malta  2  
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Death Multiplier Method  
As the case finding method is not realistic in a large metropolitan area or for a 
country as a whole, more indirect and cheaper methods for estimating prevalence have 
been developed. These methods do, however, make assumptions about the relation of 
observable events to the whole. One such method is the death multiplier method that 
was used in the United States during the 1970s (14). This method assumes a constant 
linear relation between prevalence of use and the number of deaths. It is with this 
seemingly simple assumption that the weakness of this method lies. With the advances 
made in dynamic modeling and chaos and the application of these modeling techniques 
to complex social and medical phenomena we are increasingly aware of the dangers of 
oversimplifying the models used to estimate prevalence. For example, in estimating the 
spread and incidence of the human immunodeficiency virus among intravenenous drug 
users, Comiskey (15) and Comiskey and Ruskin (16) use complex nonlinear models of 
the transmission dynamics of the disease. Substance use is also a complex 
phenomenon and many other factors, for example, mode of administration of the opiate 
used, may also influence the linearity assumption. It is widely accepted that mortality 
rates for those who smoke or sniff opiate are lower than mortality rates for those who 
inject. Changes in the purity of the opium used may also affect the user’s mortality rate, 
In addition, government policy and procedures on death notifications may delay or distort 
the number of opiate-related deaths. As a result of these limitations it is possible for the 
method to underestimate the true prevalence. The death multiplier method, however, 
has been used extensively from studies in London (13) to studies in Germany (17) and 
Rome (18). We illustrate the first application of the method to the city of Dublin from 
1990 to 1996 in the Results section.  
 
The Multivariate Indicator Method  
A simple yet comprehensive description of this method is provided by Mariani (19). 
The author states that the application of this method requires a breakdown of national 
states by regions or provinces and data indicating the prevalence of drug use. These 
data must be available for each of these regions. For at least two regions, reliable 
prevalence estimates derived independently are also required. Here, the method is 
described step by step and follows the application of the method as described for Italy 
(20). Data indicating the prevalence of drug use must be collected for a 1-year period for 
each region. The following variables may be selected as indicators:  
A Number of offenses against drug laws or addicts in jail  
B Drug-related deaths  
C Clients in treatment  
D Cases of AIDS related to IDU  
E Hospital discharges  
In addition, the population size F of the population at risk is needed. In (19) the 
population at risk was defined as the 15- to 54-year-olds in 1995. As already mentioned, 
for at least two regions reliable estimates G (maybe resulting from a cap tore-recapture 
study) are necessary. These regions are called anchor points. G (for each of the 
variables A to E) and the figure per 100,000 inhabitants for each region have to be 
calculated.  
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A_F = A x 100,000/F  
G,F = G x 100,000/F  
Principal components analysis requires standardized values for A-F to C-F 
(subtracting the mean and dividing by the standard deviate). For this analysis two factors 
are extracted and rotated, and the coefficients of the first one are saved. A linear 
regression (dependent variable: G-F, independent variable: coefficients of the first factor) 
results in estimated prevalence rates per 100,000 inhabitants. Finally, these have to be 
transformed to prevalence estimates for the regions (multiplying with F and dividing by 
100,000). This method assumes a linear relationship between the unobserved 
prevalence and the observed indicators. This assumption has however been criticized 
(21). In the Results section the limitations of the method are illustrated for the first time 
with data from Dublin, Ireland, in 1996.  
Capture-Recapture Method  
The capture-recapture method is an indirect method that generates a prevalence 
estimate based on the degree of overlap between two or more separate samples of the 
population under study. For example, when working with three samples or data sets, the 
first sample provides the individuals for marking or tagging and is returned to the 
population. The second and third sample provides the recaptures. Using the number of 
individuals caught in two or three samples and the numbers caught in one sample, it is 
possible to estimate the number not caught in any of the three samples, thus providing 
an estimate of the total population size. In addition, the method allows the confidence 
intervals of the population estimate to be calculated. It was originally used in ecological 
studies to assess the size of animal populations and in human populations to ascertain 
completion of census data. In epidemiology, different registers of the disease have been 
used as “capture” samples, with names or confidential identifiers used to tag unique 
individuals to assess the overlap between samples. The assumptions of the model are 
as follows:  
1. There is no change to the population during the investigation.  
2. There is no loss of tags; individuals can be matched from capture to recapture.  
3. For each sample, each individual has the same chance of being included in the 
sample.  
4. If using only two samples then the samples are independent. 
 
To implement the method we arrange the data from the three samples in a 2
3 
table 
with one missing cell:  
First  
Sample  
Second Sample  
Present, Third  
Sample Present  
Second Sample  
Absent, Third  
Sample Present  
Second Sample  
Present, Third  
Sample Absent  
Second Sample  
Absent, Third  
Sample Absent  
Present  X111  X121  X112  x122  
Absent  X121  X221  X212  -  
 
Let n = x111 + x121 + x211 + x221 + x112+x122 + x212. In addition, let mijk be the expected 
value for the number of individuals in the (ijk) cell. Let pijk be the underlying probability 
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corresponding to the (ijk) cell. For example, p111 is the probability of being in all samples. 
The probability of being in none of the samples is P222 and we assume p222 > 0.We have 
mijk= pijk(n/1-p222)for(i, j, k)= (2,2,2). The loglinear models available for our use and their 
interpretations are as follows:  
 
1. The three samples are independent:  
log mijk= u + u1(i) + u2(j) + u3(k)  
 
2. The third sample is independent of the first two:  
log mijk = u + u1(i) + u2(j) + u3(k) + u12(ij)  
(there are three versions of this model).  
 
3. Two pairs of samples are related:  
log mijk = u + u1(i), + u2(j) + u3(k) + u12(ij) + u23(jk)  
(there are also three versions of this model).  
 
4. All pairwise relationships are present:  
log mijk = u + u1(i), + u2(j) + u3(k) + u12(ij) + u23(jk)+u13(jk)  
The model chosen can then be used to estimate the contents of the missing cell 
and confidence limits of the total estimated population, using formulae that take account 
of specified dependencies. A detailed description of the method and its applications has 
been provided elsewhere (22-24).  
Use of this method for estimating the prevalence of drug misuse has been applied 
in diverse communities throughout the world, for example, in The Netherlands (25), 
Australia (26), Italy (27), Asia (28), and Europe (29). 
 
RESULTS  
Applying Multisource Enumeration Techniques  
Three main sources of information on drug users living in Dublin were used. The 
Central Methadone Treatment List, the Hospital Inpatient Enquiry database (known as 
HIPE), and the database for arrests in 1996. Before, the collation of the data approval 
from the Assistant Data Protection Commissioner was sought and gained. Dublin is the 
capital city of the Republic of Ireland. The 1996 census of the Total population of Ireland 
identified 3,626,087 inhabitants. This represented a 2.8% increase from the previous 
census in 1991. The population of Dublin city and county was 1,058,714. This 
represents over 29% of the total population. In addition, of those living in Dublin 430,385 
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(or 41%) are under the age of 25 years and 635,329 are between the ages of 15 and 54. 
This demographic profile is in sharp contrast to other European cities where the 
populations are considerably older. A detailed age profile of the Dublin population is 
provided in Table 2.  
The Central Methadone Treatment List is maintained jointly by the Eastern Health Board 
and the Drug Treatment Centre. It was set up in 1994 and it records those who have 
ever, since 1994, received methadone from either the Eastern Health Board, the Drug 
User Treatment Centre, or a general practitioner (GP). At present, the central list is a 
combination of notifications from approximately 15 treatment centres and 75 individual 
GPs. Notification of cases by GPs is voluntary and, as a result, not all patients being 
prescribed methadone are included in the list. The list therefore represents an 
underestimate of the numbers of those in receipt of methadone treatment. From the list, 
initials, date of birth, and sex of those on methadone in 1996 were provided. We found 
that 3170 individuals were in receipt of methadone in Dublin in 1996. The number on the 
list at any one time point in 1996 would differ from this as some individuals may be on a 
long-term maintenance program while others may be on a short detoxification program. 
The mean age of those receiving methadone in 1996 was found to be 27.24 years, with 
a standard deviation of 6.87 years. There were 2225 (70.2%) males and 920 (29.0%) 
females, and for 25 (0.8%) clients the sex was unknown.  
 
Table 2.  
Age (years) 
 0-14  15-24  25-34 35-44  45-54  >54  
Male  120,444  97,222  84,350  69,540  56,682  81,178  
Female  112,700  100,009  91,891  75,188  60,447  109,063  
Total  233,144  197,231  176,241  144,728  117,129  190,241  
Source: Census 1996. Principal Demographic Results. Central Statistics Office. 
 
The Economic and Social Research Institute, Dublin, maintains the central HIPE 
database. This database records all discharges from Irish hospitals and the primary and 
secondary diagnoses of those patients discharged. Those patients who used opiate 
were identified from the ICD-9 classification code 304.0, opioid type dependence, code 
304.7, combinations of opioid type drug with any other, and code 305.5, opioid abuse. 
As of March 1997 the central HIPE database identified 603 patients in the Dublin area 
with these codes as a primary or secondary diagnosis. These 603 patients were 
identified in 12 different Dublin hospitals. However, 92% of these cases were in four of 
the Dublin hospitals. As the central ‘HIPE database does not have access to patients’ 
initials it was decided to contact these four hospitals individually and seek their 
permission for access to this data. Permission was granted and initials, date of birth, 
sex, and postal code of 545 opiate drug users were obtained. The four hospitals involved 
in the study were St. James Hospital, Beaumont Hospital, the Mater Misericordiae 
Hospital, and the Meath and Adelaide Hospital combined. The variables recorded were 
surname, initial, sex, date of birth, and Dublin postal code. Of the 545 patients identified, 
353 (64.77%) were male and 192 (35.23%) were female.  
In 1996 the assistant police commissioner conducted a study on illicit drug use and 
related criminal activity in the Dublin metropolitan area (30). After an extensive search of 
all police records held at police station level, a database consisting of 4105 individuals 
identified with drug use was constructed from records held in 17 different police districts 
across the city. The majority of these were male, unemployed, and living at home. Males 
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accounted for 3467 (84.46%) of cases and females accounted for 638 (15.54%) of 
cases. Four out of five (80%) were in the 15- to 30-year-old age group, with the youngest 
user being 12 years and the eldest being 60 years. The principal drugs used were 
opiates (heroin and methadone) with 3817 (93%) users identified.  
From the three central and diverse data sources described above, unique 
individuals were identified within and between each of the data sources using initials, 
date of birth, sex, and postal code. To make comparisons with other European studies, 
numbers of opiate users lying between the ages of 15 and 54 years were recorded and 
prevalence rates for these age groups were computed using the 1996 Census of Ireland 
report. Details of results are provided in Table 3.  
Application of the Death Multiplier Method  
 
Table 3. Multisource Enumeration of Prevalence of Opiate Use in Dublin in 1996  
 Male Female Total 
  15-24  
(yrs) 
25-34  
(yrs)  
35-54  
(yrs)  
15-24 
(yrs)  
25-34  
(yrs)  
35-54  
(yrs)  
(15-54  
(yrs)]  
Source 1: Methadone list  925  986 338 450 375 95  3169 
Source 2: HIPE database  133  165 55 99 73 20  545 
Source 3: Police arrests  1820  1164 218 371 179 35  3787 
Total contacts  2878  2315 611 920 627 150  7501 
Individuals identified  2469  1874 534 755 506 126  6264 
Prevalence per 1000 of  
population  
25  22 4 8 6 1  10 
 
A multiplier rate of 200, based on a mortality rate of 0.5% derived from a New York 
study of heroin injectors, was used to estimate the number of drug injectors in the 
District of Columbia (DC) (14). Having applied the New York mortality rate of 0.5% to the 
75 heroin-related deaths to obtain a figure of 15,000, the number of known heroin 
addicts receiving treatment was added to arrive at a figure of 17,700. This compared 
favorably to two sample capture-recapture estimates of 19,900 and 20,400 that provided 
a cross validation to the death multiplier method.  
A study of the number of opiate dependers in parts of London also used the 
method (13). The number of deaths in the study was obtained from a comprehensive 
search of coroners’ records. The authors based their multiplier on previous UK studies 
that found death rates of 1-2% among those attending clinics for opiate use. In Germany 
mortality rates ranging from 0.65% to 3.96% were applied to opiate related deaths from 
1976 to 1995 (17).  
In 1996, government ministerial permission for access to data on opiate-related 
deaths in Dublin was sought and granted through the office of the General Registrar of 
Births, Deaths, and Marriages. The Central Statistics Office, which maintains this 
database, subsequently provided a table summarizing deaths in Dublin for ICD-9 cause 
of death code 304.0 (opioid type dependence) between 1990 and 1996. During that time 
period no deaths were assigned a code of 304.7 or 305.5. In the report from the Central 
Statistics Office it was stated that data after 1994 may change as outstanding returns 
come in and as such the data provided below are subject to considerable reporting 
delays and can be considered an underestimate of the true number of opiate related 
deaths. In addition, it is known that in Dublin the primary route of administration of 
opiates is changing from injecting to smoking and as such mortality rates would be 
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decreasing. For both of these reasons, the Dupont and Piemme (14) approach with a 
mortality rate of 0.5% was implemented. Table 4 provides the results of this analysis. 
 
Table 4. Prevalence of Opiate use in Dublin from 1990 to 1996 Using the Death 
Multiplier Method  
Year  
Number of 
Deaths  
Estimate with 0.5% 
Mortality Rate  
Numbers in  
Treatment a
 
 
Prevalence Estimate with 0.5% 
Mortality Rate + Numbers in Treatment  
1990  1  200  1609  1809  
1991  2  400  1840  2240  
1992  7  1400  1942  3342  
1993  4  800  2306  3106  
1994  11  2200  2472  4672  
1995  23  4600  3126  7726  
1996  11  2200  3635  5836 b
 
 
1996  23  4600  6264  10864(17/1000) c
 
 
a
Source: Ref. 31. (Table 4.2 and Figure 4.4).  
b
Underestimate attributable to reporting delays in death notifications of up to two years.  
c
lf we assume that the number of opiate-related deaths in 1996 will be at least the same as those 
occurring in 1995, and instead of using the number of opiate users identified from treatment we 
use the number of opiate users identified from the multisource enumeration described above. 
Using this approach we arrive at a prevalence estimate of 10,864 or 17/1000 opiate users in 
Dublin in 1996. We shall see in the next section how this result compares favorably with that 
derived using capture-recapture methods.  
 
Application of the Multivariate Indicator Method to Irish Data  
The Republic of Ireland is divided into 26 counties that are then combined for the 
provision of health-related services into eight different regions each with its own Health 
Board. Although there is some information published on a national or city level relating to 
the five data indicators discussed in the methods section, there is very little stratified 
data available for each of the Health Board Regions. There are two exceptions to this. 
One is the Health Research Board National Reports on Treated Drug Misuse, the other 
is the data on hospital discharges or H1PE database, the data from which we examined 
at Dublin city level in our section earlier. The HIPE database provides information at 
county level, which can then be collated into Health Board Region. Table 5 details the 
national data currently available at Health Board level.  
Only two indicators are available at a regional level. In addition, there are only two 
anchor points available. The Eastern Health Board anchor point refers to Dublin City 
only and the Southern Health Board anchor point may not be reliable. Because of the 
considerable, data demands of the method and the limitations in the data available, the 
method could not be reliably applied to regions within Ireland. 
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Table 5. Multiple Indicators and Anchor Points at Regional Level  
Variable  
Description  
A\In Treatment  
1996  
E\Hospital  
Discharges 
1996  
F\Population 15-
54  
Years  
G\Ancho
r  
Point  
North Eastern  0  6  170071   
Eastern  3771  731  775538  13460
a 
 
(Dublin)  (3635)  (707)  (635329)   
Midland  7  4  112079   
South Eastern  14  6  216571   
Southern  14  10  306931  1473
b 
 
Mid Western  27  3  178029   
Western  3  7  189818   
North Western  1  5  111991   
All boards  3837  772  2061028   
a
Estimate based on a capture-recapture study of opiate use in Dublin in 1996, details of which are 
below.  
b
The author states that 10 of a sample of 2095 (0.48%) of those surveyed admitted recent opiate 
use. We apply the same percentage use to the total population in the SHB region [Source: Ref. 
(10)].  
In addition, it is obvious from the geographical distribution of the data in Table 5 
that the main opiate use is within the Eastern Health Board and in particular within 
Dublin City.  
Application of the Capture-Recapture Method with Three Data Sources and Log-
Linear Modeling  
 
The method was applied using the three data sources obtained for the multi-
source enumeration study. The first stage of implementation of the method involved 
removing duplicates from the data and identifying which cases were recorded in two or 
more samples. This may be done using five types of identification available for each 
sample: 1) date of birth, 2) sex, 3) forename initial, 4) surname initial, and 5) postal code. 
Confidentiality can be maintained throughout the entire process and the identification of 
all persons remains unknown, Cases may be matched using a sort procedure on a 
standard statistical package such as SPSS/PC or SAS. Once the number of unique 
individuals within each sample and the overlap between samples have been determined, 
prevalence estimates may be obtained using the standard formulae and techniques. 
Finally using the statistical package GLIM, log-linear regression models may be fitted to 
the data to determine possible dependence between samples.  
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Prevalence estimates based on the three data sources are provided and the best 
estimates are derived after a sex and age stratification of the three data sets. Note that 
in this analysis 134 cases were removed from the police data as these did not have a 
known Dublin postal code.  
Figure 1 illustrates and summarize the overlaps between each source for all age 
groups. Table 6 provides overlaps for the 15-54 year age range.  
Using published methods (22), and the statistical modeling package GLIM together 
with macros devised by Cormack, Comiskey, and Hay, log-linear models for capture-
recapture studies were fitted. This analysis provides reliable prevalence estimates. The 
details of the best fitting model within each layer of stratification along with an estimate 
of the model fit and the resulting hidden prevalence estimate are provided in Table 7.  
Table 8 provides a detailed summary of the obtained estimates. Included are the 
known numbers of cases, the estimated hidden population, the overall estimate, and 
95% confidence intervals for these estimates.  
DISCUSSION  
It is evident from the raw data prevalence and estimated prevalence in Table 8 that 
males in the 15-24 age group represent the single largest group of opiate users. Pooling 
the three raw data sources as we did in our multisource enumeration we see that 
prevalence in this group is 25 per 1000 of population or, alternatively, it may be stated 
that a minimum of 2.5% of all males in this age group are known to be using opiates. 
Looking at the ratio of known population to hidden population we see that males 
between 35 and 54 years are the most hidden group. We may interpret this as the group 
least likely to come into contact with the medical or legal services. Those most likely to 
come into contact with services, e.g., the most visible or accessible group we see are 
males between the ages of 25 and 34. With females the same phenomenon is seen 
within the same age groups.  
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Table 6. Data from the Three Samples Illustrating the Overlaps Between Data Sources 
for Those Aged from 15 to 54 Years  
Source 3  
Source 1 Present,  
source 2 Present  
Source 1 Present,  
Source 2 Absent  
Source 1 Absent,  
Source 2 Present  
Source 1 Absent,  
Source 2 Absent  
Present  121  764  71  2831  
Absent  160  2124  193  -  
 
Table 7. Prevalence Estimates for the Hidden Population of Opiate Drug Users Showing 
the Best Fitting Model  
Group  Best Model  C
2 
 df  p Value  N  95% CI  
Males 15-24  + S1 x S2 + S2 x S3  0.30  1  .58  2935  2511-3422  
Males 25-34  + S1 x S2  9.89  2  .01  1638  1402-1904  
Males 35-54  + S1 x S2  5.31  2  .07  893  641-1239  
Females 15-24  + S1 X S2 + S2 x S3  6.77  1  .01  1023  770-1353  
Females 25-34  + S1 X S2 + S2 x S3  1.40  1  .24  533  369-759  
Females 35-54  + S1 x S2  3.67  2  .12  174  80-365  
S1 = Source 1, methadone; S2 = Source 2, hospital; S3 = Source 3, police.  
 
In the light of prevalence estimates ranging from 6264 from intensive case finding 
to over 10,864 from the death multiplier method (both methods which are known to 
provide underestimates) to 13,460 from the capture-recapture method it would seem 
prudent for planning purposes to assume that in Dublin in 1996 there were at least 
11,000 to possibly 14,000 opiate users. Opiate user here is defined in a broad context to 
cover both “problematic” and “nonproblematic” user. It should also be remembered that 
the majority of these users are male and within the 15-24 year age bracket. The wider 
implications of the findings in the present study need to be addressed. For instance we 
know that 80% of those drug users tested for Hepatitis C were found to be Hep C 
seropositive (32). Analysis of the extent and spread of prevalence of Hep C among the 
hidden group of drug users is essential for planning and provision of medical and social 
services for those affected.  
On a European comparison this estimate is in accordance with estimates 
published by other European cities. In Barcelona an opiate drug user population 
prevalence of 9.2/1000 was estimated (33). Estimates of prevalence of injecting drug 
use in Glasgow were found to be 13.5/1000 with this rising to 43.45/1000 in males aged 
between 20 and 24 years (34). High prevalence among young males is noted in our 
study also, as can be seen from Table 7 where a prevalence rate of 56/1000 is 
estimated for males aged 15-24 years. In a similar study in Setubal, Portugal, 
prevalence of opiate use among males aged 15-24 years was estimated to be 53/1000 
(private communication). Finally, in Dundee, Scotland, the prevalence of opiate use was 
estimated to be 30/1000 (35). 
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Table 8. Estimated Prevalence of Opiate Use in Specific Populations in Dublin in 1996  
 
Known  
Number  
Estimated  
Hidden  
Number  
Ratio of  
Known 
to  
Hidden  
Estimated  
Total  
95% C.I. for the 
Total Estimate  
Known  
Prevalence  
per 1000  
Population  
Estimated  
Prevalence  
Per 1000  
Population  
Male (15-24)  2469  2935  1:1.19  5404  4980-5891  25  56  
Male (25-34
a
)  1874  1638  1:0.87  3512  3276-3778  22  42  
Male (35-54)  534  893  1:1.67  1427  1175-1773  4  11  
Female (15-24
a
)  755  1023  1:1.35  1778  1525-2108  8  18  
Female (25-34)  506  533  1:1.05  1039  875-1265  6  11  
Female (35-54)  126  174  1:1.38  300  206-491  1  2  
Total  6264  7196  1:1.15  13460  12037-15306  10  21  
a 
Indicates a poor-fitting model and hence not a reliable estimate. 
 
It is both important and interesting to note how results from prevalence estimation 
techniques vary depending on the methodology used. For Dublin, results varied from 
6264 with the multisource enumeration technique to 10,864 based on the mortality 
multiplier technique to 13,460 using the capture-recap cure methodology. In this first 
instance we are measuring the number of opiate users who have come into contact with 
a service, in the second we are measuring what we may call problematic users who 
have a risk of death, and in the final analysis we are measuring the number of more 
general opiate users or non-problematic users. This disparity of results clearly 
demonstrates how important the definition of opiate use within a study is and how the 
scope of this definition is crucial to the prevalence estimate derived. With any prevalence 
estimation study, one should first clearly outline the definition of opiate use before one 
decides on an appropriate method for estimation.  
Once the definition is decided upon, then the next consideration is the availability 
of the necessary data and an analysis of the limitations of the method. While the death 
multiplier method is easy to understand and apply, data on opiate-related deaths might 
not be readily available (as was the case with this study, Government ministerial 
approval for access to the data was required). In addition {again as is the case in 
Ireland), not all opiate-related deaths may be reported or there may be a considerable 
time delay in reporting. In addition, with the death multiplier method it is important to 
choose the multiplier correctly. However, if the data is available, this method does 
provide a quick and easy approach to a minimum prevalence estimate. If a more 
comprehensive study is to be undertaken then it is recommended that a multisource 
enumeration be conducted followed by a capture-recapture study. Again, it is important 
to clearly outline the definition of opiate use prior to such a study. Finally, it is the opinion 
of the author that no one study will provide a comprehensive prevalence estimate and 
that a range of approaches, definitions, and methods need to be applied before one can 
provide policy planners with a clear picture of the profile, nature, and extent of opiate 
use.  
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It was stated at the outset by Reuter (1) that prevalence estimation ought to be a 
fundamental element of the policy decision-making process. This sentiment is reiterated 
in Refs. (36,37), in which the authors state that this role is in need of development; in 
practice, prevalence estimation has not been important enough in policy-making. Instead 
of providing gross measures to show that a city has a large drug problem what is 
required are answers to a series of questions the policy maker may pose. The first and 
perhaps most important of these is “what is the extent of the problem?” Indeed we may 
ask prior to this, what exactly is the problem and for whom? Who benefits from the 
problem and who benefits from the solution? Subsequently, policy makers may wish to 
know who is using drugs, what is the nature of the drug use, the costs incurred because 
of drug use, and whether the problem is getting better or worse. In this first 
comprehensive study of prevalence estimation in Ireland it is hoped that some of these 
questions have been addressed. In addition it is hoped that the discussion of the 
methods and an illustration of their application will provide assistance and insight for 
other similar cities worldwide. Finally in the words of N.T.J. Bailey (38):  
 
In the light of suffering on a worldwide scale, epidemic theory is a luxury 
mankind can ill afford, the world must not only be interpreted it must be 
changed.  
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